Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04800926 · ClinicalTrials.gov registry record · NA
Xavier Electromyographic Wheelchair Control for Limited Mobility Patients
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT04800926: Completed NA study, sponsored by Mayo Clinic.
NCT04800926 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04800926, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the functional mobility and self-reported satisfaction with the Xavier electromyography hands-free wheelchair control system in comparison with a standard joystick.
Primary Outcome
Questionnaire
Interventions
- DEVICE Xavier wheelchair controller
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2019-01-11 |
| Est. Completion | 2019-10-30 |
| Phase | NA |
What the finished NCT04800926 record still lists
NCT04800926 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Xavier wheelchair controller is the first listed.
NCT04800926 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04800926 about?
NCT04800926 is a clinical study titled "Xavier Electromyographic Wheelchair Control for Limited Mobility Patients". The purpose of this study is to assess the functional mobility and self-reported satisfaction with the Xavier electromyography hands-free wheelchair control system in comparison with a standard joystick.
What is the current status of trial NCT04800926?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2019-01-11. Estimated completion is 2019-10-30.
What interventions are being tested in trial NCT04800926?
The interventions under investigation include: Xavier wheelchair controller (DEVICE).
Who is sponsoring clinical trial NCT04800926?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04800926's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI